People: Intellicell Biosciences Inc (SVFC.PK)

SVFC.PK on OTC Markets Group

0.09USD
22 May 2013
Price Change (% chg)

$-0.01 (-10.00%)
Prev Close
$0.10
Open
$0.09
Day's High
$0.09
Day's Low
$0.09
Volume
10,000
Avg. Vol
51,217
52-wk High
$0.45
52-wk Low
$0.05

Search Stocks

Summary

Name Age Since Current Position

Steven Victor

 60 2011 Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary

Leonard Mazur

 2013 Interim Chief Operating Officer, Director

Michael Hershman

 2012 Director

Myron Holubiak

 2012 Director
» Insider Trading

Biographies

Name Description

Steven Victor

 Dr. Steven Victor, M.D., is Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary of Intellicell Biosciences Inc. Dr. Victor is a practicing celebrity dermatologist with over 20 years experience Author of the book “Ageless Beauty – A Dermatologist’s Guide to Looking Younger Without Plastic Surgery”, Guest Appearances on 20/20, Morning America, The Today Show, etc., along with features in nationally published fashion/style magazines. Dr. Victor is the field of Dermatology, pioneering some of the most effective and interesting treatments in skin rejuvenation today. He has lectured around the world, consulted for numerous cosmetic companies, featured in numerous magazines and featured in various Television and News segments. Dr. Victor has developed numerous consumer products for distribution through the Cosmeceuticals and Prescription skin care channels. Medicis (MRX/NYSE), a specialty pharmaceutical company that develops and markets products for the treatment of dermatological, aesthetic, and podiatric conditions, was initially launched with 6 Rx products of Dr. Victor’s including Benzashave, a patented product. Dr Victor launched the one of the first acne infomercials in 1992 and developed the products for the Cher Skin Care infomercial. Dr. Victor has held numerous teaching appointments and holds a Bachelor of Arts degree from New York University and a received his M.D. degree from New York College.

Leonard Mazur

 Mr. Leonard L. Mazur is Interim Chief Operating Officer, Director of Intellicell Biosciences Inc. Mr. Mazur has been a member of the Board of Directors since June 3, 2011. Since January 2008, Mr. Mazur has served as co-founder and Vice Chairman of Akrimax Pharmaceuticals, LLC, a privately held pharmaceutical company specializing in producing cardiovascular and general pharmaceutical drugs. Between January 2005 to May 2012, he served as Co-Founder and Chief Operating Officer of Triax Pharmaceuticals LLC, a specialty pharmaceutical company producing prescription dermatological drugs. Prior to joining Triax, he was the founder and, from 1995 to 2005, Chief Executive Officer of Genesis Pharmaceutical, Inc., a dermatological products company that marketed its products through dermatologists’ offices. In addition, Mr. Mazur has sales, marketing and business development experience from his tenures at Medicis Pharmaceutical Corporation,as executive vice president, ICN Pharmaceuticals, Inc.. Knoll Pharma (a division of BASF), and Cooper Laboratories, Inc. Mr. Mazur is a member of the Board of Trustees of Manor and is a recipient of the Ellis Island Medal of Honor.

Michael Hershman

 Mr. Michael Hershman is appointed as the Director of Intellicell Biosciences, Inc. Mr. Hershman has been president and chief executive officer of The Fairfax Group LLC, an investigative, security and crises management firm, since founding the company in 1983. Mr. Hershman is an internationally recognized on matters relating to transparency, accountability, governance, litigation and security. Over the years, Mr. Hershman has served as a senior staff investigator for the Senate Watergate Committee, as chief investigator for a joint Presidential and Congressional commission, reviewing state and federal laws on wiretapping and electronic surveillance, as chief investigator for the Federal Election Commission, as deputy staff director for the Subcommittee on International Organizations of the U.S. House of Representatives and as deputy auditor general for the Foreign Assistance Program of the U.S. Agency for International Development. In 1993, Mr. Hershman co-founded Transparency International, the independent, not-for-profit coalition promoting transparency and accountability in business and in government. For the past six years he has served Interpol as a member of the International Group of Experts on Corruption, and for the past twelve years, he has sat on the board of the International Anti-Corruption Conference Committee. Since 2007, Mr. Hershman has been a member of the board of directors and the executive committee of the Center for International Private Enterprise. For the past twelve years Mr. Hershman has been a member of Interpol’s International Group of Experts on Corruption and now serves as Vice Chairman. Mr. Hershman is also on the board of the International Anti-Corruption Conference Committee, the Financial Coalition against Child Pornography, a project of the National Center for Missing and Exploited Children and he is a member of the Advisory Council of the George Mason University School of Information Technology and Engineering.

Myron Holubiak

 Mr. Myron Z. Holubiak is appointed as the Director of Intellicell Biosciences, Inc. Mr. Holubiak is the former President of Roche Laboratories, Inc. He held this position from December 1998 to August 2001. From August 2001 to June 2002, Mr. Holubiak was President, Chief Operating Officer and member of the Board of Directors of iPhysicianNet, Inc., a video detailing company. From July 2002 to April 2007 Mr. Holubiak was President and Chief Operating Officer of HealthSTAR Communications, Inc., a health care marketing communications network of 16 companies. Currently, Mr. Holubiak is the President and a member of the board of directors of 1-800-Doctors, Inc., a medical referral company that provides consumers with access to physicians and hospitals. From April 2004 to July 2008 Mr. Holubiak served on the board of directors of Nastech Pharmaceuticals Company, Inc. (now Marina Biotech, Inc.). Mr. Holubiak is also a member of the board of directors of Venture Biosciences, Inc. Mr. Holubiak is currently the Chairman of the Board of Directors of BioScrip, Inc, a specialty pharmaceutical company.

Basic Compensation

Name Fiscal Year Total

Steven Victor

 290,000

Leonard Mazur

 --

Michael Hershman

 --

Myron Holubiak

 --
As Of 30 Dec 2011

Options Compensation

Name Options Value

Steven Victor

 0 0

Leonard Mazur

 0 0

Michael Hershman

 0 0

Myron Holubiak

 0 0

Insider Trading

Name Shares Traded Price

VICTOR STEVEN A

 1,000,000 $0.00

VICTOR STEVEN A

 500,000 $0.00
» Full list on Insider Trading
Search Stocks